FORSTEO(R) Receives Positive Opinion from the European Committee for Medicinal Products for Human Use for the Treatment of Gluco
INDIANAPOLIS, February 22 /PRNewswire/ --
- If approved, bone formation agent for osteoporosis would be available for new patient population
Eli Lilly and Company (NYSE: LLY) today announced that…